Chester County News and Community Website
YPrime‘s cloud-based technology unifies data sources and expedites clinical trial data collection. Electronic clinical outcome assessment (eCOA) and interactive response technology (IRT) platforms introduce greater speed, precision and data quality to clinical trials. We design configurable software to meet study-specific requirements, and support the needs of sponsors, patients and sites throughout a clinical trial. Our consulting services help clients implement data standards to simplify downstream processes and optimize clinical systems to make informed decisions through the power of their own data. YPrime’s technology and service offerings enable sponsors to move faster and more efficiently to their next development milestone.
MALVERN, PA — YPrime has been named a Leader in the Everest Group’s 2025 Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment, a recognition that underscores the …
YPrime Named Leader in Everest Group’s 2025 eCOA Products Assessment Read More MALVERN, PA — YPrime has solidified its reputation as a leader in responsible and sustainable business practices by earning a top-tier EcoVadis rating and medal. Ranking in the top 35 percent …
YPrime Earns Prestigious EcoVadis Medal for Sustainability Efforts Read More MALVERN, PA — YPrime has introduced groundbreaking updates to its electronic clinical outcome assessment (eCOA) platform, announcing a new AI Migration Tool designed to transform the way clinical trials are conducted …
YPrime Unveils AI-Powered Innovations to Revolutionize Global Clinical Trials Read More MALVERN, PA — YPrime has announced the launch of its Automated Data Change Form (DCF), an innovative feature within the latest release of its electronic clinical outcome assessment (eCOA) 7.x platform. …
YPrime Unveils Automated Data Change Form to Revolutionize Clinical Trial Management Read More MALVERN, PA — YPrime has announced that Dr. Karl McEvoy, Vice President of eCOA and Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute’s eCOA Consortium for 2025.
YPrime’s Dr. Karl McEvoy Named Co-Director of eCOA Consortium Read More MALVERN, PA — YPrime has announced its formal commitment to the United Nations (UN) Global Compact, a global initiative promoting universal principles on human rights, labor, the environment, and anti-corruption. With …
YPrime Joins UN Global Compact, Reinforcing Commitment to Sustainability Read More MALVERN, PA — YPrime has been recognized as a Trailblazer in the Everest Group’s Clinical Trial Patient Engagement Products Assessment. This accolade highlights YPrime’s dedication to enhancing patient participation and engagement …
YPrime Honored as Trailblazer in Clinical Trial Patient Engagement Read More MALVERN, PA — YPrime has launched its cutting-edge eCOA 7.0 SaaS platform, poised to transform the clinical trial industry. This launch reflects YPrime’s dedication to integrating advanced technology with user-centric …
YPrime Unveils Revolutionary eCOA 7.0 Platform Read More MALVERN, PA — YPrime has released a research report titled “Endocrinology Clinical Trials: Advancing Research with the Help of eCOA Technologies.” This report, derived from a survey of clinical trial …
YPrime’s New Report Highlights Role of eCOA Technologies in Endocrinology Clinical Trials Read More MALVERN, PA — YPrime has unveiled a new glucometer functionality that integrates seamlessly with its electronic Clinical Outcome Assessment (eCOA) platform. This innovation, developed alongside diabetes patients, aims to revolutionize …
YPrime Launches Groundbreaking Glucometer Feature for Clinical Trials Read More